University of Iowa Hospitals and Clinics

Clinical Trial Details

Short Title
GSK Summit COPD Research Study
Official Title

GSK Summit COPD Research Study

Description

We are pleased to inform you that our medical center is participating in a clinical research study for individuals with chronic obstructive pulmonary disease (COPD).  The purpose of the study is to evaluate the long term benefit of an investigational drug for COPD. We are notifying you and others that have COPD of the opportunity to participate in this study.

You may qualify to participate in this study if you are between the ages of 40 and 80 and have moderate COPD. You must also have a history of smoking and a history or be at risk of heart disease. We have enclosed some brief information for you to consider. 

If you are interested in learning more about the study or have any questions, please contact us. Contacting us does not mean you are obligated to participate or that you will be eligible to participate. Eligibility will depend on a range of criteria.


Thank you for your consideration, we look forward to hearing from you!

Start Date
September 25, 2013
End Date
March 25, 2014
Gender Preference
None
Age Group
40 - 80 years
Principal Investigator
Dr. Alejandro Comellas
Contact Info

Kim Sprenger, RN BSN

319-353-8862

kimberly-sprenger@uiowa.edu

Department
Department or Field of Study
Keywords
copd, cardiovascular disease, lung, breathing ;

We welcome your feedback! Please help us improve your experience on our website by completing a brief survey.